A rticle a b stra c t-We examined five individuals and obtained information concerning six other members from two unrelated families, nearly all of whom developed chorea after age 50 (one patient developed chorea at age 40). The severity of chorea progressed in all patients and became disabling in some individuals approximately 15 years after onset. Cognitive impairment was absent or minimal, All five examined patients were cognitively normal, even 10 to 30 years following the onset of chorea. Formal neuropsychometric testing demonstrated mild cognitive impairment in two individuals. Nevertheless, all patients were able to maintain employment or carry on with their usual household tasks until chorea was severe. One individual first became demented 30 years after the onset of chorea. Neuroimaging (with CT or MRI) in four patients failed to demonstrate significant caudate or putaminal atrophy 8 to 15 years following the onset of chorea, Three other family members (who were not available for examination) were said to have suffered chorea (without any mental decline) beginning after age 50, with subsequent survival of 20 years (in one) and 30 years (in two). Given this constellation of history and findings, three experienced neurologists and two medical geneticists concluded that these patients had a familial chorea syndrome distinct from Huntington's disease (HD). However, ge netic analysis of the trinucleotide (CAG) repeat length associated with HD (in 4pl6.3) determined repeat lengths of 44 and 4fi in four patients tested (within the HD range). We conclude that these patients have HD and that such families represent further convincing examples of significant phenotypic variation for HD. NEUROLOGY 1995;45:443-447
T he m o st com m only recognized form of fam ilial chorea is H untington1» disease (HD). This condition is inexorably progressive and is associated with de m entia, psychiatric abnorm alities, and other neuro logic signs in addition to chorea. Age of onset is usually betw een 30 and 50 y e a rs,1,2 Typically, dete rioration results in death a t an average age of 54 years, 15 to 20 years after disease onsets Clinical varian ts include a juvenile form, w ith rigidity as a prom inent feature,•• and late-onset HD.™ There, a re , h o w e v e r, o th e r fo rm s of fa m ilia l chorea. For example, benign familial chorea, char acterized by childhood o nset and a relatively b e nign co u rse,7 sta n d s in c o n tra st to HD, w hereas d e n ta to -ru b ro -p a llid a l-lu y sia n atro p h y (DRPLA), another autosom al dom inant condition, m ay closely mimic HD.S O ther familial disorders w ith chorea as a prom inent feature have also been described.9,10
T here are instances of late-onset, nonhereditary ch o rea w ith o u t o th e r neurologic m a n ife sta tio n s d e sig n a te d as senile chorea. Some have a rg u e d th a t senile chorea m ay frequently rep resen t lateonset H D .11 However, HD does not account for all reported cases of senile chorea,12 and there is g e netic evidence for senile chorea being a distinct e n tity from H D .1;U1
We recently encountered two unrelated fam ilies w ith 11 m em bers affected by adult-onset chorea. Each pedigree displayed a p attern compatible w ith an autosom al dom inant mode of inheritance. Cog n itiv e an d p sy ch iatric dysfunction w ere a b se n t, mild, or only present m any years after the onset of chorea. Coupled w ith a prolonged, i'elatively benign course and a lack of neuroim aging abnorm alities, these features led th ree experienced neurologists and two medical geneticists expert in HD to con clude th a t these patients had a familial chorea syn drome th a t was distinct from HD.
The recent discovery of the HD gene and its a s sociated trinucleotide (CAG) repeat expansion h a s 0 J 0 1 facilitated confirmation of diagnosis in symp tomatic patients. 15 We applied polymerase chain re action (PCR) analysis of the HD trinucleotide re peat sequence16'18 to affected members of these two fam ilies with late-onset chorea to determine whether they indeed represented a unique disorder of familial late-onset chorea or HD with an atypical presentation.
Methods. Clinical information. Pedigrees of two unre lated families with late-onset chorea are illustrated in ñgures 1 and 2. Case reports concerning affected mem bers are presented below. PCR analyses. Trinucleotide repeat length analyses were performed on two members from each family (III. 8 and III. 10 from family 1 and III. 12 and 111.14 from fam ily 2). Nuclear DNA was isolated by extraction from leukocytes using the method of Kunkel et al. 19 The CAG repeat size was measured as previously described. 17 As sessment of the trinucleotide repeat length included 76 base pairs on non-CAG sequences, which were then sub tracted from the observed size. The resulting value was divided by three to obtain the CAG repeat length.
Case reports. Family 1 (figure 1 ). III.8. The proband had a 15-year history of mild, generalized, slowly pro gressive chorea when first seen at age 65 years. She was a homemaker and continued to perform all her normal household duties without difficulty 15 years after onset of chorea. Apart from chorea, she had no other com plaints. On direct questioning, she thought that she might have had a mild decline in memory, but her hus band disagreed with this impression. Medical history was significant only for a 15-year history of hypertension and mild hypercholesterolemia.
Neurologic findings were limited to mild generalized chorea and hyperkinetic dysarthria. Her Mini-Mental State Examination20 score was 38 of 38 (within the nor mal range).
She scored in the average range on the following neu ropsychological tests: Wechsler Adult Intelligence Scale-Revised (WAIS-R) ( An MRI of the brain performed 15 years after the onset of chorea showed mild generalized atrophy ( figure  3a) . A blood smear for acanthocytes, slit-1 amp examina tion, urine screen for inborn errors of metabolism, gen eral chemistry panel, ceruloplasmin level, antinuclear antibody (ANA) level, thyroid-stim ulating hormone (TSH) level, vitamin B12 and folic acid levels, and hema tology group were all normal or negative.
III.10. The brother of the proband was initially seen at age 63, after a 10-year history of mild generalized chorea. He had no complaints apart from chorea. He con tinued to operate a successful farm independently, per forming all his usual chores. He was not aware of any change in his cognitive capacity. On direct questioning, his wife thought that he may have had a subtle decline in memory and had become somewhat indecisive since age 61 years. He had no history of psychiatric illness.
Neurologic examination showed mild generalized chorea and mildly impaired rapid alternating movements bilaterally. The Mini-Mental State Examination revealed impaired delayed verbal recall (he recalled one of four words learned after a 5-minute delay) but was otherwise normal (total score: 35/38).
Neuropsychological testing revealed limited abnor malities. These were restricted to impaired verbal learn ing and retention on the AVLT (he learned eight of 15 words after five trials and recalled three after 30 min utes). The WAIS-R was performed in the average range (Pull Scale IQ = 97), consistent with his education and occupational background. A brain MRI 10 years after the onset of chorea showed mild generalized cerebral atrophy (figure 3b). A blood smear for acanthocytes, slit-lamp ex amination, chemistry panel, vitamin B12 and folic acid, FTA-ABS, and TSH were normal or negative. An ANA titer was 1:160.
II at a ge 85, 33 years after the onset of chorea. She weighed 60 pounds at the time of death. Her mother, father, and two sisters all died in the sev enth and eighth decades of life. None had any neurologic or psychiatric disorder. Her two other siblings died im mediately after birth and at age 16 from diphtheria. One paternal uncle was said to have had "St. Vitus' dance" at one time and died in his thirties (of unknown cause). No other relatives were known to have had any neurologic diseases.
DNA analyses. The upper allele CAG trinucleotide re peat length was 46 units in both patients IIL8 and III. 10 from family 1 and 44 units in both patients III. 12 and III. 14 from family 2. An upper allele repeat sequence of >36 triplets is considered to be within the HD range.14
Discussion. The two families described here share certain features that are atypical of HD; (1) demen tia was not a prominent feature; (2) survival follow ing onset of chorea was prolonged, with deceased patients dying an average of 28 years after chorea began; and (3) neuroimaging, performed between 8 and 15 years after the onset of chorea in four indi viduals, showed no disproportionate caudate or putaminal atrophy.
Dementia was absent or minimal in four of the five examined patients, as it was for all four de ceased patients from family 1 who died after a 20to 30-year history of chorea. In contrast, significant cognitive and psychiatric decline is a hallmark of HD, usually leading to disability within a few years after diagnosis.21 Patient III. 14 from family 2 did show a decline on serial neuropsychological test scores; however, his chorea and dysarthria signifi cantly interfered with psychological testing, con founding the results. Despite his scores, he was still able to provide a logical history 17 years after symptom onset. Likewise, III. 10 from family 1 demonstrated abnormalities on memory testing but continued to function as a capable farmer. Patients with late-onset HD often exhibit a milder degree of dementia than those with earlier onset; however, the largest series of late-onset HD patients noted that all 25 examined patients were definitely de mented within 7 years of the onset of chorea.5 The individuals in our series did not demonstrate de mentia, not even of a mild degree, until between 8 and 30 years after chorea onset.
The patients in these two families remained free from disability for at least 10 years following the onset of chorea. Survival of affected members in our two families was longer than the 15 to 20 years typically seen in HD (28 years on average in the five deceased patients).3 The 33-year survival after onset of chorea seen in patient 11.10 (family 2) is one of the longest ever reported in an HD patient. In one large series,1 no patient survived more than 27 years. However, MacMillan et al22 recently re ported several individuals originally thought to have benign hereditary chorea who had HD proven by identification of trinucleotide expansion.
Consistent absence of disproportionate caudate and putaminal atrophy is also atypical for HD. In dividual patients with advanced HD and normal neuroimaging are unusual.21 In a prior series of pa tients with late-onset HD,5 all nine patients who underwent CT had caudate atrophy. Others have shown that loss of putamen volume may be a more sensitive finding than caudate atrophy in "mild HD" (in which cognitive processing is minimally af fected). 23 Despite their atypical clinical features, the DNA analysis in these patients indicates that they have inherited the mutation associated with HD. Their CAG trinucleotide repeat lengths fall within the range identified in late-onset HD.24 In a study of 133 patients with late-onset HD from 107 separate families, there was a significant negative correla tion between the length of repeat and age of onset for the total cohort. However, for persons with onset age greater than 60, there was no significant correlation.24 With increasing age of onset, the ef fect of the repeat length on onset age appears to di minish.
The reason for the atypical phenotypic expres sion in our patients is unclear. Some of the pheno typic variability in HD can be attributed to the CAG repeat sequence length. For example, repeat length is inversely correlated w ith age of onset.15,25-27 Repeat length can also be correlated with disease severity. Patients with juvenile-onset HD tend to have a more severe and rapidly pro gressive course4 and generally exhibit long repeat sequence lengths.15,25'27 However, there are notable examples of marginally prolonged repeat lengths occurring in childhood-onset HD. 22 Repeat length alone explains about 50% of the total variance in onset age.25 Furthermore, in a large genetic analy sis series restricted to late-onset HD, repeat length accounted for only 7% of the variation in age of onset for persons beyond the age of 50 years.24 Likewise, there was no significant correlation be tween age of onset and size of the lower allele re peat length or the sex of the affected parent or grandparent in this series.24 Finally, a small num ber of patients clinically diagnosed as having HD have not shown an expanded CAG repeat with a novel gene on 4pl6.3. In at least four such cases, studies have excluded 4pl6.3 as the region respon sible for the HD phenotype. 28 That all cases in our two families aggregated as late-onset HD suggests that other genetic factors may be involved. When it is determined how the CAG repeat expansion relates to HD, it may be come apparent how certain clinical features are produced. Accumulating evidence suggests that the protein product of IT15 may be a DNA-binding pro tein involved in transcriptional regulation. 29 If an expanded polyglutamine (glutamine being the amino acid encoded by CAG) stretch leads to al tered expression of other genes, a wide range of phenotypic variation might be explained. In this re gard, aspects of another autosomal dominant condi tion, DRPLA, which may closely mimic HD clini cally, are of great interest. Until recently, in some instances DRPLA and HD could only be differenti ated by neuropathologic examination (in which major involvement of the globus pallidus, subtha lamic nucleus, and dentate nuclei distinguished DRPLA from HD).8 DRPLA is associated with an other CAG repeat expansion, this one occurring on chromosome 12,30 Such expansions may allow for the development of specific neurologic features in cluding chorea, dementia, and psychiatric distur bances. Further genetic evaluations of families with unusual HD phenotypes, such as the patients described, may contribute to an understanding of the biology of phenotypic expression in HD,
